Drugs

Durability and Rapidity of Response to Anakinra in Patients with Rheumatoid Arthritis
pp. 2493-2501(9)
Author: Michael H. Schiff

Medication Overuse Headache from Antimigraine Therapy: Clinical Features, Pathogenesis and Management
pp. 2503-2514(12)
Authors: Timothy R. Smith; Jill Stoneman

Chronic Urticaria: Aetiology, Management and Current and Future Treatment Options
pp. 2515-2536(22)
Authors: Martina M.A. Kozel; Ruth A. Sabroe

Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
pp. 2537-2565(29)
Authors: André J. Scheen

Duloxetine: In Stress Urinary Incontinence
pp. 2567-2573(7)
Authors: Paul L. McCormack; Gillian M. Keating

Duloxetine: A Viewpoint by Richard J. Millard
pp. 2574-2575(2)
Author: Richard J. Millard

Duloxetine: A Viewpoint by Naoki Yoshimura and Michael B. Chancellor
pp. 2574-2575(2)
Authors: Naoki Yoshimura; Michael B. Chancellor

Insulin Detemir: A Review of its Use in the Management of Type 1 and 2 Diabetes Mellitus
pp. 2577-2595(19)
Authors: Therese M. Chapman; Caroline M. Perry

Cefditoren Pivoxil: A Review of its Use in the Treatment of Bacterial Infections
pp. 2597-2618(22)
Authors: Keri Wellington; Monique P. Curran